Wang Limin, Tran Ivy, Seshareddy Kiran, Weiss Mark L, Detamore Michael S
Department of Biomedical Engineering, University of Michigan , Ann Arbor, Michigan, USA.
Tissue Eng Part A. 2009 Aug;15(8):2259-66. doi: 10.1089/ten.tea.2008.0393.
Bone marrow-derived mesenchymal stem cells (BMSCs) have long been considered the criterion standard for stem cell sources in musculoskeletal tissue engineering. The true test of a stem cell source is a side-by-side comparison with BMSCs. Human umbilical cord-derived mesenchymal stromal cells (hUCMSCs), one such candidate with high potential, are a fetus-derived stem cell source collected from discarded tissue (Wharton's jelly) after birth. Compared with human BMSCs (hBMSCs), hUCMSCs have the advantages of abundant supply, painless collection, no donor site morbidity, and faster and longer self-renewal in vitro. In this 6-week study, a chondrogenic comparison was conducted of hBMSCs and hUCMSCs in a three-dimensional (3D) scaffold for the first time. Cells were seeded on polyglycolic acid (PGA) scaffolds at 25 M cells/mL and then cultured in identical conditions. Cell proliferation, biosynthesis, and chondrogenic differentiation were assessed at weeks 0, 3, and 6 after seeding. At weeks 3 and 6, hUCMSCs produced more glycosaminoglycans than hBMSCs. At week 6, the hUCMSC group had three times as much collagen as the hBMSC group. Immunohistochemistry revealed the presence of collagen types I and II and aggrecan in both groups, but type II collagen staining was more intense for hBMSCs than hUCMSCs. At week 6, the quantitative reverse transcriptase polymerase chain reaction (RT-PCR) revealed less type I collagen messenger RNA (mRNA) with both cell types, and more type II collagen mRNA with hBMSCs, than at week 3. Therefore, it was concluded that hUCMSCs may be a desirable option for use as a mesenchymal cell source for fibrocartilage tissue engineering, based on abundant type I collagen and aggrecan production of hUCMSCs in a 3D matrix, although further investigation of signals that best promote type II collagen production of hUCMSCs is warranted for hyaline cartilage engineering.
长期以来,骨髓间充质干细胞(BMSCs)一直被视为肌肉骨骼组织工程中干细胞来源的标准。对一种干细胞来源的真正检验是将其与BMSCs进行对比。人脐带间充质基质细胞(hUCMSCs)就是这样一种极具潜力的候选细胞,它是一种从出生后废弃组织(华通氏胶)中获取的胎儿源干细胞。与人类BMSCs(hBMSCs)相比,hUCMSCs具有供应丰富、采集无痛、无供体部位并发症以及体外自我更新更快且持续时间更长等优点。在这项为期6周的研究中,首次在三维(3D)支架中对hBMSCs和hUCMSCs进行了软骨生成比较。将细胞以25 M细胞/毫升的密度接种到聚乙醇酸(PGA)支架上,然后在相同条件下培养。在接种后第0、3和6周评估细胞增殖、生物合成和软骨生成分化情况。在第3周和第6周,hUCMSCs产生的糖胺聚糖比hBMSCs更多。在第6周,hUCMSC组的胶原蛋白含量是hBMSC组的三倍。免疫组织化学显示两组均存在I型和II型胶原蛋白以及聚集蛋白聚糖,但hBMSCs的II型胶原蛋白染色比hUCMSCs更强。在第6周,定量逆转录聚合酶链反应(RT-PCR)显示,与第3周相比,两种细胞类型的I型胶原蛋白信使核糖核酸(mRNA)含量均减少,而hBMSCs的II型胶原蛋白mRNA含量更多。因此得出结论,基于hUCMSCs在3D基质中能大量产生I型胶原蛋白和聚集蛋白聚糖,hUCMSCs可能是用于纤维软骨组织工程的理想间充质细胞来源,不过对于透明软骨工程而言,仍需进一步研究最能促进hUCMSCs产生II型胶原蛋白的信号。